Poulsen Sally-Ann, Wilkinson Brendan L, Innocenti Alessio, Vullo Daniela, Supuran Claudiu T
Eskitis Institute for Cell and Molecular Therapies, Griffith University, Brisbane Innovation Park, Don Young Road, Nathan, Qld. 4111, Australia.
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4624-7. doi: 10.1016/j.bmcl.2008.07.010. Epub 2008 Jul 10.
A library of 10 novel benzenesulfonamides containing triazole-tethered phenyl 'tail' moieties were synthesized by a Cu(I) catalyzed 1,3-dipolar cycloaddition reaction (DCR) (i.e., click chemistry) between 4-azido benzenesulfonamide and a panel of variously substituted phenyl acetylenes. These compounds were very effective inhibitors (low nanomolar) of the human mitochondrial carbonic anhydrase isozymes VA and VB. Mitochondrial carbonic anhydrases are potential targets for anti-obesity therapies, acting to reduce lipogenesis through a novel mechanism of action. The inhibitors reported here should prove valuable as lead compounds to further investigate the potential of CA inhibition for this novel therapeutic application.
通过4-叠氮基苯磺酰胺与一系列不同取代的苯乙炔之间的铜(I)催化1,3-偶极环加成反应(DCR)(即点击化学),合成了一个包含10种含有三唑连接的苯基“尾巴”部分的新型苯磺酰胺库。这些化合物是人类线粒体碳酸酐酶同工酶VA和VB的非常有效的抑制剂(低纳摩尔)。线粒体碳酸酐酶是抗肥胖疗法的潜在靶点,通过一种新的作用机制来减少脂肪生成。本文报道的抑制剂作为先导化合物,对于进一步研究碳酸酐酶抑制在这种新型治疗应用中的潜力应该是有价值的。